Nanobiotix S.A. (NBTX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$33.88
-1.90%
Mkt Cap $1.94B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $51.55M | $3.53M | -93.15% | $0.30 | -$0.46 | -250.74% |
| Q3 2025 Sep 30, 2025 | $23.90M | $31.36M | +31.22% | -$0.25 | -$0.13 | +45.89% |
| Q2 2025 Apr 2, 2025 | $3.55M | -$21.64M | -709.22% | -$0.62 | -$1.01 | -63.46% |
| Q4 2024 Nov 12, 2024 | $10.35M | $9.99M | -3.45% | -$0.51 | -$0.50 | +2.47% |
| Q2 2024 Apr 24, 2024 | — | $36.20M | — | -$0.83 | -$0.33 | +60.40% |
| Q4 2023 Nov 13, 2023 | $3.95M | $3.59M | -9.09% | -$0.59 | -$0.87 | -47.60% |
| Q1 2023 Mar 28, 2023 | — | $1.86M | — | — | -$0.95 | — |
| Q4 2022 Nov 9, 2022 | — | $695.08K | — | — | -$0.79 | — |
| Q1 2022 Mar 30, 2022 | $1.43M | $752.78K | -47.33% | -$1.05 | -$0.54 | +48.56% |
| Q3 2021 Aug 9, 2021 | $11.44K | $11.86K | +3.75% | -$0.60 | -$1.04 | -73.76% |
| Q2 2021 May 5, 2021 | -$1.81K | $15.94K | +981.75% | -$1.01 | -$0.57 | +43.06% |
| Q4 2020 Oct 23, 2020 | $2.20M | $41.63K | -98.11% | -$1.09 | -$1.02 | +5.92% |
| Q2 2020 Apr 30, 2020 | — | $35.17K | — | — | -$1.37 | — |
| Q2 2019 Jun 30, 2019 | — | $42.01K | — | — | -$1.30 | — |
| Q4 2018 Dec 31, 2018 | — | $1.70M | — | — | -$1.08 | — |
| Q2 2018 Jun 30, 2018 | — | $2.39M | — | — | -$0.75 | — |
| Q4 2017 Dec 31, 2017 | — | $2.16M | — | — | -$0.86 | — |
| Q2 2017 Jun 30, 2017 | — | $2.14M | — | — | -$0.87 | — |
| Q4 2016 Dec 31, 2016 | — | $2.50M | — | — | -$0.79 | — |
| Q2 2016 Jun 30, 2016 | — | $3.37M | — | — | -$0.76 | — |
| Q4 2015 Dec 31, 2015 | — | $2.57M | — | — | -$0.76 | — |
| Q2 2015 Jun 30, 2015 | — | $1.84M | — | — | -$0.58 | — |
| Q4 2014 Dec 31, 2014 | — | $2.30M | — | — | -$0.50 | — |
| Q2 2014 Jun 30, 2014 | — | $1.36M | — | — | -$0.42 | — |
| Q4 2013 Dec 31, 2013 | — | $1.23M | — | — | -$0.47 | — |
| Q2 2013 Jun 30, 2013 | — | $869.01K | — | — | -$0.51 | — |
| Q4 2012 Dec 31, 2012 | — | $650.90K | — | — | -$0.42 | — |
| Q2 2012 Jun 30, 2012 | — | -$538.42K | — | — | -$0.37 | — |
| Q4 2011 Dec 31, 2011 | — | $886.97K | — | — | -$2.23 | — |
| Q2 2011 Jun 30, 2011 | — | $984.73K | — | — | -$2.47 | — |